Publications | Centre de recherche CERVO

Export 18 results:

Filtres: Keyword is Prevalence [Enlever les filtres]

2014

Medehouenou TC, Ayotte P, Carmichael P-, Kröger E, Verreault R, Lindsay J, et al. Plasma polychlorinated biphenyl and organochlorine pesticide concentrations in dementia: the Canadian Study of Health and Aging. Environ Int. 2014;69:141-7.

2013

Potvin O, Forget H, Préville M, Berbiche D, Chagnon YC, Hudon C. Relationship between cortisol level and prevalent/incident cognitive impairment and its moderating factors in older adults. Int Psychogeriatr. 2013;25(2):252-62.

Gagnon C, Bélanger L, Ivers H, Morin CM. Validation of the Insomnia Severity Index in primary care. J Am Board Fam Med. 2013;26(6):701-10.

2012

Ellis JG, Perlis ML, Neale LF, Espie CA, Bastien CH. The natural history of insomnia: focus on prevalence and incidence of acute insomnia. J Psychiatr Res. 2012;46(10):1278-85.

Potvin O, Hudon C, Forget H, Grenier S, Dubé M, Lorrain D, et al. Prevalence of psychiatric disorders in community-dwelling older men and women with cognitive impairment no dementia: results from the ESA study. Aging Ment Health. 2012;16(2):218-27.

Grenier S, Potvin O, Hudon C, Boyer R, Préville M, Desjardins L, et al. Twelve-month prevalence and correlates of subthreshold and threshold anxiety in community-dwelling older adults with cardiovascular diseases. J Affect Disord. 2012;136(3):724-32.

2011

Potvin O, Hudon C, Dion M, Grenier S, Préville M. Anxiety disorders, depressive episodes and cognitive impairment no dementia in community-dwelling older men and women. Int J Geriatr Psychiatry. 2011;26(10):1080-8.

Grenier S, Préville M, Boyer R, O'Connor K, Béland S-, Potvin O, et al. The impact of DSM-IV symptom and clinical significance criteria on the prevalence estimates of subthreshold and threshold anxiety in the older adult population. Am J Geriatr Psychiatry. 2011;19(4):316-26.

Savard J, Ivers H, Villa J, Caplette-Gingras A, Morin CM. Natural course of insomnia comorbid with cancer: an 18-month longitudinal study. J Clin Oncol. 2011;29(26):3580-6.

Morin CM, LeBlanc M, Bélanger L, Ivers H, Mérette C, Savard J. Prevalence of insomnia and its treatment in Canada. Can J Psychiatry. 2011;56(9):540-8.

Provencher MD, Hawke LD, Thienot E. Psychotherapies for comorbid anxiety in bipolar spectrum disorders. J Affect Disord. 2011;133(3):371-80.

2010

Sarsour K, Van Brunt DL, Johnston JA, Foley KA, Morin CM, Walsh JK. Associations of nonrestorative sleep with insomnia, depression, and daytime function. Sleep Med. 2010;11(10):965-72.

2009

Morin CM, Bélanger L, LeBlanc M, Ivers H, Savard J, Espie CA, et al. The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med. 2009;169(5):447-53.

Savard J, Villa J, Ivers H, Simard S, Morin CM. Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol. 2009;27(31):5233-9.

2006

Provencher MD, Ladouceur R, Dugas MJ. [Comorbidity in generalized anxiety disorder: prevalence and course after cognitive-behavioural therapy]. Can J Psychiatry. 2006;51(2):91-9.

Voyer P, Verreault R, Mengue PN, Morin CM. Prevalence of insomnia and its associated factors in elderly long-term care residents. Arch Gerontol Geriatr. 2006;42(1):1-20.

2004

Alméras N, Després J-, Villeneuve J, Demers M-, M-A Roy, Cadrin C, et al. Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry. 2004;65(4):557-64.

1995

Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome. Am J Hum Genet. 1995;57(5):1006-18.

Financement / Soutien / Partenaires

© Gouvernement du Québec, 2018